top of page

Board of Directors

Bringing together a highly experienced, multidisciplinary bio/med-tech team with a proven track record of successful platform & commercial market development.

people-photo-jonathan-fleming-chairman-square.jpg

Co-founder, Board Chair

Jonathan Flemming, MPA

Managing Partner Pimlico Pond Investments

Board member QurAlis

Senior Lecturer, Trust Center for MIT Entrepreneurship

518A1431-6CB6-46E5-A613-E8FF77438C70_edited.jpg

Co-founder, CEO & Board Member

Anthony R. DePasqua, MBA

20+ years leading product & market development efforts in the healthcare space

Significant business development and strategic positioning experience at industry leading companies

itj7ioeudpa49vim8zev.webp

Board Member

Jason Camm, 

Managing Director & Chief Medical Officer
Thiel Capital

people-photo-kasper-roet-ceo-square-1.jpg

Co-Founder, Board Member

Kasper Roet, PhD

CEO and co-founder of QurAlis Corporation and is also co-founder and serves on the Board of Directors of EnClear Therapies. Kasper is a passionate neuroscientist and patient advocate

NunezGladys.jpg

Board Observer

Gladys Nunez

Director Amgen Ventures

©2021 by EnClear Therapies.

bottom of page